Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and

Martina Karasová1,2, Jiřina Procházková1, Zuzana Tylichová1

  • 1Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic.

Cancers
|September 9, 2022
PubMed

Insights

The aryl hydrocarbon receptor (AhR) is upregulated in colon cancer. Its disruption limits tumor cell proliferation and fatty acid metabolism, suggesting AhR as a potential therapeutic target.

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Metabolism

Background:

  • The aryl hydrocarbon receptor (AhR) influences cellular processes like proliferation and immune response.
  • AhR may also regulate energy balance and cellular metabolism.
  • AhR is found to be upregulated in colon cancer epithelial cells.

Purpose of the Study:

  • To investigate the role of AhR in colon cancer cell proliferation and metabolism.
  • To analyze the impact of AhR on fatty acid synthesis in colon cancer.

Main Methods:

  • Utilized wild-type and AhR knockout (AhR KO) human colon cancer cell lines (HCT116, HT-29).
  • Assessed cell proliferation, cell cycle progression, and ATP production.
  • Quantified mRNA levels of key enzymes in fatty acid biosynthesis (e.g., SCD1) and related signaling pathways (e.g., PI3K/Akt, SREBP1).

Main Results:

  • AhR KO cells exhibited decreased proliferation, altered cell cycle, and reduced ATP production.
  • Reduced mRNA levels of key fatty acid synthesis enzymes (e.g., SCD1) were observed in AhR KO cells.
  • Loss of AhR correlated with reduced expression/activity of the PI3K/Akt pathway and lipogenic regulators like SREBP1.

Conclusions:

  • Disruption of AhR activity in colon tumor cells can limit proliferation, potentially by suppressing endogenous fatty acid metabolism.
  • AhR may play a significant role in colon tumor cell metabolism.
  • Further research is warranted to explore the mechanistic links between AhR overexpression and colon cancer cell metabolism.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K